NanoEcho
0,07 SEK
-3,23 %
Mindre end 1K følgere
NANECH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
-3,23 %
+6,46 %
-37,59 %
-23,01 %
-78,28 %
-40,22 %
-
-
-57,73 %
NanoEcho is active in healthcare, with a main focus in rectal cancer diagnostics. The company is active in the clinical stage, where a new diagnostic method is being developed to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide a correct diagnosis and individualized treatment. NanoEcho was founded in 2013 and has its headquarters in Lund.
Læs mereMarkedsværdi
19,3 mio. SEK
Aktieomsætning
2,44 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
12.2
2026
Årsrapport '25
30.4
2026
Delårsrapport Q1'26
28.5
2026
Generalforsamling '26